GlaxoSmithKline Pakistan Limited (GLAXO)

PHARMACEUTICALSACIALLSHRKMIALLSHRKSE100KSE100PRMII30

373.01

+0.75%

As of 10-Jul-2026

52 Week RangeCurrent: 373.01

293.09459.94

Updated: 10-Jul-2026

1M+6.9%

3M+11.1%

1Y+4.6%

3Y+410.7%

5Y+305.5%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 09-Jul-2026

P/E

11.22x

P/B

3.25x

P/S

1.75x

EV/Sales

6.36x

EV/EBITDA

22.08x

Showing 37 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	16.81	7.73	1.68	20.52	31.48
DPS	7.00	0.00	0.00	10.00	17.00
BVPS	65.90	66.11	68.06	88.79	105.74
PER	22.02x	47.89x	220.37x	18.04x	11.76x
Div Yield	1.89%	0.00%	0.00%	2.70%	4.59%
PBV	5.62	5.60	5.44	4.17	3.50
EV/Sales	2.98x	2.71x	2.30x	1.82x	1.66x
Price/Sales	3.22x	2.82x	2.37x	1.93x	1.79x
EV/EBITDA	16.88x	39.39x	-47.78x	11.13x	5.99x
EV/Gross Profit	11.22x	15.55x	32.67x	7.25x	4.50x

Metric	2021	2022	2023	2024	2025
Gross Margin	26.56%	17.40%	7.05%	25.15%	37.00%
EBITDA Margin	17.65%	6.87%	-4.82%	16.39%	27.79%
Operating Margin	15.49%	4.77%	-6.71%	14.50%	25.64%
Pretax Margin	20.25%	12.20%	4.38%	17.12%	25.32%
Net Margin	14.60%	5.89%	1.08%	10.68%	15.21%

Metric	2021	2022	2023	2024	2025
ROE	27.84%	11.72%	2.50%	26.17%	32.36%
ROA	18.94%	7.46%	1.45%	15.71%	20.94%
ROTA	20.10%	6.05%	-9.05%	21.33%	35.30%
ROCE	25.67%	8.82%	-14.14%	29.46%	47.54%